呼吸道合胞病毒临床试验招募信息（全球在招）

这里汇总了全球正在招募患者的 呼吸道合胞病毒（国际通用名 respiratory syncytial virus）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖RSV等说法。

正在招募的呼吸道合胞病毒新药试验

• Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or Without Maternal RSV Vaccination

  III 期招募中法国NCT07232706

• Clinical Trial of Recombinant RSV Vaccine (CHO Cell) (Adjuvanted) in Chinese Population Aged 18 Years and Older.

  I 期 / II 期招募中中国NCT07582796

• Human Interferon α1b Inhalation Solution Against Respiratory Syncytial Virus in Children With Lower Respiratory Tract Infections

  III 期招募中中国NCT06363370

• Epidemiological Characteristics and Clinical Burden of RSV Infection in Children Under 24 Months in Ho Chi Minh City (2026-2028)

  不适用招募中VietnamNCT07640581

• A Phase 1 Study to Evaluate the Safety, Reactogenicity and Immunogenicity of YKYY025 Injection

  I 期招募中中国NCT07694557

• Safety and Immunogenicity Study of Revaccination With SCB-1019T in Healthy Adults

  I 期招募中美国NCT06843317

• rBCG-N-RSV Vaccine in Adults Aged 60 Years and Older

  II 期招募中GreeceNCT07762014

• Virological Surveillance of Acute Respiratory Infection in Primary Health Care in Metropolitan France

  不适用招募中法国NCT07599449

• Peginterferon α-2b Injection for Aerosol Therapy in Pediatric Respiratory Syncytial Virus Pneumonia

  不适用招募中中国NCT06881056

• COVID-19 Impact on RSV Emergency Presentations

  不适用招募中英国NCT04959734

• Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell)

  III 期招募中中国NCT07272434

• A Clinical Trial of SIBP-A16 Injection in Healthy Adults

  早期 I 期招募中中国NCT07106918